These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24671433)

  • 1. Neuropsychological care and rehabilitation of cancer patients with chemobrain: strategies for evaluation and intervention development.
    Jean-Pierre P; Johnson-Greene D; Burish TG
    Support Care Cancer; 2014 Aug; 22(8):2251-60. PubMed ID: 24671433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating functional near-infrared spectroscopy in the characterization, assessment, and monitoring of cancer and treatment-related neurocognitive dysfunction.
    Jean-Pierre P
    Neuroimage; 2014 Jan; 85 Pt 1():408-14. PubMed ID: 23831530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroepidemiology of cancer and treatment-related neurocognitive dysfunction in adult-onset cancer patients and survivors.
    Jean-Pierre P; McDonald BC
    Handb Clin Neurol; 2016; 138():297-309. PubMed ID: 27637965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response.
    Boykoff N; Moieni M; Subramanian SK
    J Cancer Surviv; 2009 Dec; 3(4):223-32. PubMed ID: 19760150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive performance of older women who have survived cancer.
    Buckwalter JG; Crooks VC; Petitti DB
    Int J Neurosci; 2005 Sep; 115(9):1307-14. PubMed ID: 16048807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive dysfunction in survivors of childhood brain tumors.
    Ullrich NJ; Embry L
    Semin Pediatr Neurol; 2012 Mar; 19(1):35-42. PubMed ID: 22641074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin and cisplatin induced cognitive impairment: The possible mechanisms and interventions.
    Ongnok B; Chattipakorn N; Chattipakorn SC
    Exp Neurol; 2020 Feb; 324():113118. PubMed ID: 31756316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemobrain in underserved African American breast cancer survivors: a qualitative study.
    Rust C; Davis C
    Clin J Oncol Nurs; 2013 Apr; 17(2):E29-34. PubMed ID: 23538262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive dysfunction and cancer: which consequences in terms of disease management?
    Joly F; Rigal O; Noal S; Giffard B
    Psychooncology; 2011 Dec; 20(12):1251-8. PubMed ID: 21254307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive dysfunction among cancer survivors.
    Asher A
    Am J Phys Med Rehabil; 2011 May; 90(5 Suppl 1):S16-26. PubMed ID: 21765260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renaming "chemobrain".
    Hurria A; Somlo G; Ahles T
    Cancer Invest; 2007 Sep; 25(6):373-7. PubMed ID: 17882646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of cognitive rehabilitation in cancer survivors.
    Cherrier MM; Anderson K; David D; Higano CS; Gray H; Church A; Willis SL
    Life Sci; 2013 Oct; 93(17):617-22. PubMed ID: 24012579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemobrain: a critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy.
    Wang XM; Walitt B; Saligan L; Tiwari AF; Cheung CW; Zhang ZJ
    Cytokine; 2015 Mar; 72(1):86-96. PubMed ID: 25573802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychiatric disorders in cancer patients.
    Baile WF
    Curr Opin Oncol; 1996 May; 8(3):182-7. PubMed ID: 8794151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive changes in cancer survivors.
    Nail LM
    Cancer Nurs; 2006; 29(2 Suppl):48-54. PubMed ID: 16779956
    [No Abstract]   [Full Text] [Related]  

  • 16. A feasibility study of group cognitive rehabilitation for cancer survivors: enhancing cognitive function and quality of life.
    Schuurs A; Green HJ
    Psychooncology; 2013 May; 22(5):1043-9. PubMed ID: 22570263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of EEG biofeedback on reducing postcancer cognitive impairment.
    Alvarez J; Meyer FL; Granoff DL; Lundy A
    Integr Cancer Ther; 2013 Nov; 12(6):475-87. PubMed ID: 23584550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion Tensor Imaging and Neurobehavioral Outcome in Children With Brain Tumors Treated With Chemotherapy.
    Baron Nelson M; Compton P; Macey PM; Patel SK; Jacob E; O'Neil S; Ogren J; Finlay JL; Harper RM
    J Pediatr Oncol Nurs; 2016; 33(2):119-28. PubMed ID: 26219302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes of neurocognitive functions as result of cancer treatment in children and adolescents].
    Vlcková I; Pavelková K; Kepák T; Pilát M; Bajciová V; Mazánek P; Sterba J; Jelínek M
    Klin Onkol; 2008; 21(5):294-302. PubMed ID: 19202961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Women's experiences of cognitive changes or 'chemobrain' following treatment for breast cancer: a role for occupational therapy?
    Player L; Mackenzie L; Willis K; Loh SY
    Aust Occup Ther J; 2014 Aug; 61(4):230-40. PubMed ID: 24499127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.